Therapie des malignen Glaukoms

Unterlauft, Jan Darius; Schawkat, Megir; Häner, N.S.; Lincke, Joel; Zinkernagel, Martin

doi:10.1007/s00347-022-01718-z

Cited by 1 publication

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Drug therapy is the first-line treatment for malignant glaucoma, involving the local use of potent ciliary muscle paralytics, topical anti-inflammatory drugs, and aqueous humor suppressants, coupled with systemic administration of hyperosmotic agents. If conservative treatment proves ineffective, further interventions such as vitrectomy combined with iridotomy or iridectomy, with or without ICL removal, may be necessary ( 54 , 55 , 57 ).…”

Section: Malignant Glaucomamentioning

confidence: 99%

Causes and management strategies for elevated intraocular pressure after implantable collamer lens implantation

Gong,

Deng,

Dang

et al. 2024

Front. Med.

View full text Add to dashboard Cite

With the widespread application of Implantable Collamer Lens (ICL) implantation surgery in the field of myopia correction, a comprehensive understanding of its potential complications, especially those related to intraocular pressure (IOP), becomes crucial. This article systematically reviews various complications that may lead to IOP elevation after ICL surgery. Firstly, common complications after ICL surgery, including residual viscoelastic, steroid response, and excessive vault of the ICL, are detailed, emphasizing their potential impact on intraocular pressure. Regarding residual viscoelastic, we delve into its direct relationship with postoperative elevated IOP and possible preventive measures. For steroid response, we stress the importance of timely adjustment of steroid therapy and monitoring intraocular pressure. Additionally, excessive vault of the ICL is considered a significant potential issue, and we elaborate on its mechanism and possible management methods. In further discussion, we focus on relatively rare complications such as Toxic Anterior Segment Syndrome (TASS), Urrets-Zavalia Syndrome (UZS), Pigment Dispersion Syndrome (PDS), and malignant glaucoma. For these relatively rare complications, this review thoroughly explores their potential mechanisms, emphasizes the importance of prevention, and provides guidance for early diagnosis and treatment. This is a comprehensible review that aims to offer eye care professionals a comprehensive understanding and effective management guidance for complications of elevated IOP after ICL surgery, ultimately providing optimal care for patients’ visual health.

show abstract

Section: Malignant Glaucomamentioning

confidence: 99%